Using an in vivo model to ascertain how COVID-19 convalescent plasma therapy may be more effective to treat patients

Convalescent plasma therapy (CPT), which entails using plasma containing anti-SARS-CoV-2 antibodies taken from recovered individuals, has achieved mixed results in treating aged or immunosuppressed individuals suffering from severe COVID-19.